Characterization of inflammatory mediator release from purified human lung mast cells. 1986

R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein

The release of inflammatory mediators (histamine, PGD2, TxB2, and LTC4) from purified human lung mast cells was characterized by kinetic and anti-IgE dose-response parameters. The relative rate of mediator release was histamine greater than PGD2 = TxB2 greater than LTC4, with one half maximal release occurring at approximately 2, 5, and 10 min, respectively. In 2 experiments, stimulation with anti-IgE caused significant quantities of platelet-activating factor (PAF) to appear rapidly (2 min) in the cell pellet; cell-associated PAF declined to low levels by 45 min. The optimal concentration of anti-IgE for the release of the arachidonate cyclooxygenase metabolites PGD2 and TxB2 (0.3 microgram/ml) was 10- to 30-fold less than that required for the release of histamine and LTC4 (3 to 10 micrograms/ml), suggesting that these release processes may have differential IgE Fc receptor cross-linking requirements. At optimal histamine release, the magnitude of the release of each arachidonate metabolite was found to correspond to the magnitude of histamine release, however, suggesting that the 2 processes are linked either in series or in parallel.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011457 Prostaglandins D Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects. PGD
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
March 2010, Journal of neuroinflammation,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
November 1988, The American review of respiratory disease,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
October 1976, Journal of immunology (Baltimore, Md. : 1950),
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
January 1993, Gastroenterology,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
December 1994, Allergy,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
October 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
August 1985, The American review of respiratory disease,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
October 1988, Photo-dermatology,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
October 1982, Clinical allergy,
R P Schleimer, and D W MacGlashan, and S P Peters, and R N Pinckard, and N F Adkinson, and L M Lichtenstein
January 1985, International archives of allergy and applied immunology,
Copied contents to your clipboard!